Background: We compared the enzymatic, coagulant, and neuromuscular activities of two variants (yellow—CDRy and white—CDRw) of Crotalus durissus ruruima venom with a sample of C. d. terrificus (CDT) venom and examined their neutralization by antivenom against CDT venom. Methods: The venoms were screened for enzymatic and coagulant activities using standard assays, and electrophoretic profiles were compared by SDS-PAGE. Neutralization was assessed by preincubating venoms with crotalic antivenom and assaying the residual activity. Results: SDS-PAGE showed that the venoms had similar electrophoretic profiles, with the main bands being phospholipase A2 (PLA2), serine proteinases, L-amino acid oxidase (LAAO), and phosphodiesterase. CDRy venom had the highest proteolytic and LAAO activities, CDRw venom had greater PLA2 and esterolytic activities at the highest quantity tested, and CDT had greater PLA2 activity than CDRy. CDRw and CDT venoms had similar proteolytic and LAAO activities, and CDRy and CDT venoms had comparable esterolytic activity. None of the venoms altered the prothrombin time (PT), but all of them decreased the activated partial thromboplastin time (aPPT); this activity was neutralized by antivenom. The minimum coagulant dose potency was CDRw >> CDRy > CDT. All venoms had thrombin-like activity that was attenuated by antivenom. CDRy and CDRw venoms showed α-fibrinogenolytic activity. All venoms partially cleaved the β-chain. CDRy and CDT venoms caused neuromuscular facilitation (enhanced muscle contractions) followed by complete blockade, whereas CDRw venom caused only blockade. Antivenom neutralized the neuromuscular activity to varying degrees. Conclusions: These findings indicate that while CDR and CDT venoms share similarities, they also differ in some enzymatic and biological activities and in neutralization by antivenom. Some of these differences could influence the clinical manifestations of envenomation by C. d. ruruima and their neutralization by the currently used therapeutic antivenom.
Purpose: Genetic discoveries have provided etiological insight into autism spectrum disorder (ASD) such that genetic testing has become standard of care. To date, consensus about which genes are robustly associated with autism liability, and which are not, is inconsistent. Consequently, different curated ASD gene lists are applied in diagnostic testing, pre-clinical model development, and the design of precision therapeutics. Methods: We address this issue using the Evaluation of Autism Gene Link Evidence (EAGLE) framework, which allows for a protocolized and replicable curation of genes. Additionally, we compared the functional- and expression- characteristics of EAGLE-curated genes. Results: We curated 222 genes and found 78 genes with definitive EAGLE-evidence for association with autism: 43 with moderate evidence, and 99 with limited evidence for a role in ASD (noting all 222 genes are associated with the broader category of neurodevelopmental disorders (NDDs)). The top 10 EAGLE-scoring genes are NRXN1-SCN2A-MECP2-CHD8-RNU4-2-DDX3X-SHANK3-PTEN-FOXP1 , and MBD5 . Conclusion: EAGLE allows curation of evidence for association of genes with autism, as opposed to with NDDs broadly. Our analysis also revealed differential patterns of enrichment and expression profiles at the brain and cellular level, suggesting the biological relevance of differentiating ASD and the broader NDD-phenotype.
Entre los estudios toxicológicos de los venenos de serpientes existe un sesgo histórico hacia la comprensión de los venenos de las serpientes con colmillos frontales (vipéridos y elápidos), debido a que se consideran de mayor importancia médica. En consecuencia, se ha desatendido el estudio de los venenos y toxinas de las serpientes aglifas y con colmillos maxilares traseros (opistoglifas), haciendo que la mayoría de las especies de colúbridos carezcan de información sobre la composición o función de su veneno. Sin embargo, en las últimas dos décadas numerosos estudios han expuesto la increíble diversidad de toxinas y actividades biológicas de los venenos de los colúbridos. No obstante, estas investigaciones solo han revelado parcialmente su riqueza y variabilidad, convirtiéndolas en uno de los más interesantes y promisorios campos de investigación para la búsqueda de nuevos tipos de proteínas y funciones enzimáticas. En este capítulo resumimos la información disponible sobre las toxinas y venenos de los colúbridos colombianos, así como la información disponible sobre su epidemiología y su significado biológico. Además, contrastamos esa información con sus posibles aplicaciones, datos evolutivos y perspectivas futuras, con la esperanza de aumentar el interés de la comunidad científica por este asombroso grupo de serpientes «no-venenosas» y en su mayoría inofensivas.
Among toxinological studies of snake venoms there has been a historical bias towards front-fanged snakes (viperids and elapids), based on their higher medical relevance. This caused rear-fanged and aglyphous colubrid species to be left neglected in terms of the availability and generation of venom-related data. However, several studies in the last two decades have partially unveiled the diverse array of toxins that lies hidden in colubrid venoms. This research has turned colubrid venoms into a new and interesting group to search for novel protein scaffolds and functions. Most colubrid species lack information about their venom composition or function. In this chapter, we summarize the available information about the venom of Colombian colubrids integrating it with the available information about their epidemiology and their biological significance. Also, we contrast that information with its possible applications, evolutionary data, and future perspectives, hoping to enhance the interest of the scientific community for this amazing group of venomous but generally harmless snakes.